LLY

1,076.38

+1.14%↑

JNJ

206

-0.29%↓

ABBV

230.57

+1.92%↑

UNH

325.96

-0.53%↓

AZN

92.47

+0.97%↑

LLY

1,076.38

+1.14%↑

JNJ

206

-0.29%↓

ABBV

230.57

+1.92%↑

UNH

325.96

-0.53%↓

AZN

92.47

+0.97%↑

LLY

1,076.38

+1.14%↑

JNJ

206

-0.29%↓

ABBV

230.57

+1.92%↑

UNH

325.96

-0.53%↓

AZN

92.47

+0.97%↑

LLY

1,076.38

+1.14%↑

JNJ

206

-0.29%↓

ABBV

230.57

+1.92%↑

UNH

325.96

-0.53%↓

AZN

92.47

+0.97%↑

LLY

1,076.38

+1.14%↑

JNJ

206

-0.29%↓

ABBV

230.57

+1.92%↑

UNH

325.96

-0.53%↓

AZN

92.47

+0.97%↑

Search

Twist Bioscience Corp

Open

SectorHealthcare

33.68 -2.69

Overview

Share price change

24h

Current

Min

33.14

Max

35.32

Key metrics

By Trading Economics

Income

-48M

-27M

Sales

3M

99M

EPS

-0.45

Profit margin

-27.41

Employees

979

EBITDA

3.2M

-21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+18.43% upside

Market Stats

By TradingEconomics

Market Cap

31M

1.9B

Previous open

36.37

Previous close

33.68

News Sentiment

By Acuity

50%

50%

166 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

22 Dec 2025, 23:54 UTC

Major Market Movers

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22 Dec 2025, 19:08 UTC

Acquisitions, Mergers, Takeovers

Correction to Alphabet to Buy Intersect Article

22 Dec 2025, 17:21 UTC

Acquisitions, Mergers, Takeovers

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22 Dec 2025, 16:46 UTC

Acquisitions, Mergers, Takeovers

Alphabet to Buy Intersect for $4.75 Billion in Cash

22 Dec 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22 Dec 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22 Dec 2025, 22:31 UTC

Earnings

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22 Dec 2025, 22:31 UTC

Earnings

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22 Dec 2025, 22:30 UTC

Earnings

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22 Dec 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 Dec 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22 Dec 2025, 21:37 UTC

Acquisitions, Mergers, Takeovers

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22 Dec 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22 Dec 2025, 21:35 UTC

Acquisitions, Mergers, Takeovers

Capricorn to Acquire Prospective Package From Tempest Minerals

22 Dec 2025, 21:35 UTC

Acquisitions, Mergers, Takeovers

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22 Dec 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22 Dec 2025, 20:52 UTC

Acquisitions, Mergers, Takeovers

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22 Dec 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22 Dec 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22 Dec 2025, 19:49 UTC

Acquisitions, Mergers, Takeovers

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22 Dec 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22 Dec 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 Dec 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22 Dec 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22 Dec 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22 Dec 2025, 18:30 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22 Dec 2025, 18:23 UTC

Acquisitions, Mergers, Takeovers

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22 Dec 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22 Dec 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22 Dec 2025, 17:06 UTC

Acquisitions, Mergers, Takeovers

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

18.43% upside

12 Months Forecast

Average 38.5 USD  18.43%

High 42 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

166 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat